150 related articles for article (PubMed ID: 28070689)
1. Redispensing of medicines unused by patients: a qualitative study among stakeholders.
Bekker CL; Gardarsdottir H; Egberts TC; Bouvy ML; van den Bemt BJ
Int J Clin Pharm; 2017 Feb; 39(1):196-204. PubMed ID: 28070689
[TBL] [Abstract][Full Text] [Related]
2. Patient and medication factors associated with preventable medication waste and possibilities for redispensing.
Bekker CL; van den Bemt BJF; Egberts ACG; Bouvy ML; Gardarsdottir H
Int J Clin Pharm; 2018 Jun; 40(3):704-711. PubMed ID: 29721736
[TBL] [Abstract][Full Text] [Related]
3. Key factors underlying the willingness of patients with cancer to participate in medication redispensing.
Smale EM; Egberts TCG; Heerdink ER; van den Bemt BJF; Bekker CL
Res Social Adm Pharm; 2022 Aug; 18(8):3329-3337. PubMed ID: 34973931
[TBL] [Abstract][Full Text] [Related]
4. Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study.
Smale EM; van den Bemt BJF; Heerdink ER; Desar IME; Egberts TCG; Bekker CL;
JAMA Oncol; 2024 Jan; 10(1):87-94. PubMed ID: 37971730
[TBL] [Abstract][Full Text] [Related]
5. Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey.
Bekker C; van den Bemt B; Egberts TC; Bouvy M; Gardarsdottir H
BMJ Open; 2019 May; 9(5):e024767. PubMed ID: 31092644
[TBL] [Abstract][Full Text] [Related]
6. What does it cost to redispense unused medications in the pharmacy? A micro-costing study.
Bekker CL; Gardarsdottir H; Egberts ACG; Molenaar HA; Bouvy ML; van den Bemt BJF; Hövels AM
BMC Health Serv Res; 2019 Apr; 19(1):243. PubMed ID: 31014325
[TBL] [Abstract][Full Text] [Related]
7. Redispensing of expensive oral anticancer medicines: A practical application.
Akgöl K; van Merendonk LN; Barkman HJ; van Balen DE; van den Hoek HL; Klous MG; Hendrikx JJ; Huitema AD; Beijnen JH; Nuijen B
J Oncol Pharm Pract; 2024 Apr; 30(3):519-526. PubMed ID: 37192749
[TBL] [Abstract][Full Text] [Related]
8. How do people conceptualise the reuse of medicines? An interview study.
Alhamad H; Patel N; Donyai P
Int J Pharm Pract; 2018 Jun; 26(3):232-241. PubMed ID: 28795460
[TBL] [Abstract][Full Text] [Related]
9. Operation Donate: defining the value of redispensing medications donated by individuals.
Glanville M; Brady R; Miller S
J Am Pharm Assoc (2003); 2014; 54(5):542-7. PubMed ID: 25216885
[TBL] [Abstract][Full Text] [Related]
10. Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
Auta A; Strickland-Hodge B; Maz J
Int J Clin Pharm; 2016 Aug; 38(4):960-7. PubMed ID: 27194098
[TBL] [Abstract][Full Text] [Related]
11. Factors Influencing Public Willingness to Reuse the Unused Stored Medications in Jordan: A Cross-Sectional Study.
Alhamad H; Jaber D; Abu-Farha R; Albahar F; Edaily SM; Donyai P
Healthcare (Basel); 2022 Dec; 11(1):. PubMed ID: 36611535
[TBL] [Abstract][Full Text] [Related]
12. Inpatients Self-Administration of Medication: Stakeholders' views and prerequisites.
van Herpen-Meeuwissen LJM; Djodikromo MF; Maat B; van den Bemt BJF; Bekker CL; van Onzenoort HAW
J Clin Nurs; 2023 Jun; 32(11-12):2709-2721. PubMed ID: 35596267
[TBL] [Abstract][Full Text] [Related]
13. Stakeholder Views on the Idea of Medicines Reuse in the UK.
Donyai P; McCrindle R; Hui TKL; Sherratt RS
Pharmacy (Basel); 2021 Apr; 9(2):. PubMed ID: 33923745
[TBL] [Abstract][Full Text] [Related]
14. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
15. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
Lipworth W; Doran E; Kerridge I; Day R
Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
[TBL] [Abstract][Full Text] [Related]
16. Developing a national medicines information strategy in Finland--a stakeholders' perspective on the strengths, challenges and opportunities in medicines information.
Hämeen-Anttila K; Luhtanen S; Airaksinen M; Pohjanoksa-Mäntylä M
Health Policy; 2013 Jul; 111(2):200-5. PubMed ID: 23683473
[TBL] [Abstract][Full Text] [Related]
17. Actual versus recommended storage temperatures of oral anticancer medicines at patients' homes.
Vlieland ND; van den Bemt B; van Riet-Nales DA; Bouvy ML; Egberts A; Gardarsdottir H
J Oncol Pharm Pract; 2019 Mar; 25(2):382-389. PubMed ID: 29187027
[TBL] [Abstract][Full Text] [Related]
18. The Launch of the European Patients' Academy on Therapeutic Innovation in the Netherlands: A Qualitative Multi-Stakeholder Analysis.
van Rensen A; Voogdt-Pruis HR; Vroonland E
Front Med (Lausanne); 2020; 7():558. PubMed ID: 33072776
[No Abstract] [Full Text] [Related]
19. Reasons why medicines are returned to Swedish pharmacies unused.
Ekedahl AB
Pharm World Sci; 2006 Dec; 28(6):352-8. PubMed ID: 17221141
[TBL] [Abstract][Full Text] [Related]
20. Assessment of knowledge and awareness of safe disposal of unused or expired medication in Saudi Arabia: A cross-sectional study.
Althagafi A; Alshibani M; Alshehri S; Noor A; Baglagel A; Almeleebia T
Saudi Pharm J; 2022 Nov; 30(11):1672-1678. PubMed ID: 36465848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
